Skip to main content
Top
Published in: BMC Clinical Pathology 1/2011

Open Access 01-12-2011 | Research article

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer

Published in: BMC Clinical Pathology | Issue 1/2011

Login to get access

Abstract

Background

The aim of the study was to develop a virtual microscopy enabled method for assessment of Ki-67 expression and to study the prognostic value of the automated analysis in a comprehensive series of patients with breast cancer.

Methods

Using a previously reported virtual microscopy platform and an open source image processing tool, ImageJ, a method for assessment of immunohistochemically (IHC) stained area and intensity was created. A tissue microarray (TMA) series of breast cancer specimens from 1931 patients was immunostained for Ki-67, digitized with a whole slide scanner and uploaded to an image web server. The extent of Ki-67 staining in the tumour specimens was assessed both visually and with the image analysis algorithm. The prognostic value of the computer vision assessment of Ki-67 was evaluated by comparison of distant disease-free survival in patients with low, moderate or high expression of the protein.

Results

1648 evaluable image files from 1334 patients were analysed in less than two hours. Visual and automated Ki-67 extent of staining assessments showed a percentage agreement of 87% and weighted kappa value of 0.57. The hazard ratio for distant recurrence for patients with a computer determined moderate Ki-67 extent of staining was 1.77 (95% CI 1.31-2.37) and for high extent 2.34 (95% CI 1.76-3.10), compared to patients with a low extent. In multivariate survival analyses, automated assessment of Ki-67 extent of staining was retained as a significant prognostic factor.

Conclusions

Running high-throughput automated IHC algorithms on a virtual microscopy platform is feasible. Comparison of visual and automated assessments of Ki-67 expression shows moderate agreement. In multivariate survival analysis, the automated assessment of Ki-67 extent of staining is a significant and independent predictor of outcome in breast cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bloom K, Harrington D: Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol. 2004, 121: 620-630. 10.1309/Y73U8X72B68TMGH5.CrossRefPubMed Bloom K, Harrington D: Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol. 2004, 121: 620-630. 10.1309/Y73U8X72B68TMGH5.CrossRefPubMed
2.
go back to reference Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002, 8: 1323-1327. 10.1038/nm791.CrossRefPubMed Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002, 8: 1323-1327. 10.1038/nm791.CrossRefPubMed
3.
go back to reference Chen W, Reiss M, Foran DJ: A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics. IEEE Trans Inf Technol Biomed. 2004, 8: 89-96. 10.1109/TITB.2004.828891.CrossRefPubMed Chen W, Reiss M, Foran DJ: A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics. IEEE Trans Inf Technol Biomed. 2004, 8: 89-96. 10.1109/TITB.2004.828891.CrossRefPubMed
4.
go back to reference Chung GG, Zerkowski MP, Ghosh S, Camp RL, Rimm DL: Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest. 2007, 87: 662-669. 10.1038/labinvest.3700543.CrossRefPubMed Chung GG, Zerkowski MP, Ghosh S, Camp RL, Rimm DL: Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest. 2007, 87: 662-669. 10.1038/labinvest.3700543.CrossRefPubMed
5.
go back to reference Corletto V, Verderio P, Giardini R, Cipriani S, Di Palma S, Rilke F: Evaluation of residual cellularity and proliferation on preoperatively treated breast cancer: a comparison between image analysis and light microscopy analysis. Anal Cell Pathol. 1998, 16: 83-93.CrossRefPubMedPubMedCentral Corletto V, Verderio P, Giardini R, Cipriani S, Di Palma S, Rilke F: Evaluation of residual cellularity and proliferation on preoperatively treated breast cancer: a comparison between image analysis and light microscopy analysis. Anal Cell Pathol. 1998, 16: 83-93.CrossRefPubMedPubMedCentral
6.
go back to reference Kolles H, Forderer W, Bock R, Feiden W: Combined Ki-67 and Feulgen stain for morphometric determination of the Ki-67 labelling index. Histochemistry. 1993, 100: 293-296. 10.1007/BF00270049.CrossRefPubMed Kolles H, Forderer W, Bock R, Feiden W: Combined Ki-67 and Feulgen stain for morphometric determination of the Ki-67 labelling index. Histochemistry. 1993, 100: 293-296. 10.1007/BF00270049.CrossRefPubMed
7.
go back to reference Layfield LJ, Saria EA, Conlon DH, Kerns BJ: Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance. J Surg Oncol. 1996, 61: 177-184. 10.1002/(SICI)1096-9098(199603)61:3<177::AID-JSO3>3.0.CO;2-8.CrossRefPubMed Layfield LJ, Saria EA, Conlon DH, Kerns BJ: Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance. J Surg Oncol. 1996, 61: 177-184. 10.1002/(SICI)1096-9098(199603)61:3<177::AID-JSO3>3.0.CO;2-8.CrossRefPubMed
8.
go back to reference Lehr HA, Hansen DA, Kussick S, Li M, Hwang H, Krummenauer F, Trouet S, Gown AM: Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol. 1999, 30: 1314-1320. 10.1016/S0046-8177(99)90062-X.CrossRefPubMed Lehr HA, Hansen DA, Kussick S, Li M, Hwang H, Krummenauer F, Trouet S, Gown AM: Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol. 1999, 30: 1314-1320. 10.1016/S0046-8177(99)90062-X.CrossRefPubMed
9.
go back to reference Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K: The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin. 1996, 122: 687-692. 10.1007/BF01209033.CrossRef Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K: The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin. 1996, 122: 687-692. 10.1007/BF01209033.CrossRef
10.
go back to reference Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blamey RW, Ellis IO: Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer. 1995, 71: 146-149. 10.1038/bjc.1995.30.CrossRefPubMedPubMedCentral Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blamey RW, Ellis IO: Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer. 1995, 71: 146-149. 10.1038/bjc.1995.30.CrossRefPubMedPubMedCentral
11.
go back to reference Querzoli P, Albonico G, Ferretti S, Rinaldi R, Magri E, Indelli M, Nenci I: MIB-1 proliferative activity in invasive breast cancer measured by image analysis. Journal of Clinical Pathology. 1996, 49: 926-930. 10.1136/jcp.49.11.926.CrossRefPubMedPubMedCentral Querzoli P, Albonico G, Ferretti S, Rinaldi R, Magri E, Indelli M, Nenci I: MIB-1 proliferative activity in invasive breast cancer measured by image analysis. Journal of Clinical Pathology. 1996, 49: 926-930. 10.1136/jcp.49.11.926.CrossRefPubMedPubMedCentral
12.
go back to reference Querzoli P, Ferretti S, Albonico G, Magri E, Scapoli D, Indelli M, Nenci I: Application of Quantitative-Analysis to Biologic Profile Evaluation in Breast-Cancer. Cancer. 1995, 76: 2510-2517. 10.1002/1097-0142(19951215)76:12<2510::AID-CNCR2820761216>3.0.CO;2-Q.CrossRefPubMed Querzoli P, Ferretti S, Albonico G, Magri E, Scapoli D, Indelli M, Nenci I: Application of Quantitative-Analysis to Biologic Profile Evaluation in Breast-Cancer. Cancer. 1995, 76: 2510-2517. 10.1002/1097-0142(19951215)76:12<2510::AID-CNCR2820761216>3.0.CO;2-Q.CrossRefPubMed
13.
go back to reference Stromberg S, Bjorklund MG, Asplund C, Skollermo A, Persson A, Wester K, Kampf C, Nilsson P, Andersson AC, Uhlen M: A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. Proteomics. 2007, 7: 2142-2150. 10.1002/pmic.200700199.CrossRefPubMed Stromberg S, Bjorklund MG, Asplund C, Skollermo A, Persson A, Wester K, Kampf C, Nilsson P, Andersson AC, Uhlen M: A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. Proteomics. 2007, 7: 2142-2150. 10.1002/pmic.200700199.CrossRefPubMed
14.
go back to reference Sullivan CA, Ghosh S, Ocal IT, Camp RL, Rimm DL, Chung GG: Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Hum Pathol. 2009, 40: 156-165. 10.1016/j.humpath.2008.07.005.CrossRefPubMed Sullivan CA, Ghosh S, Ocal IT, Camp RL, Rimm DL, Chung GG: Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Hum Pathol. 2009, 40: 156-165. 10.1016/j.humpath.2008.07.005.CrossRefPubMed
15.
go back to reference Turashvili G, Leung S, Turbin D, Montgomery K, Gilks B, West R, Carrier M, Huntsman D, Aparicio S: Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis. BMC Cancer. 2009, 9: 165-10.1186/1471-2407-9-165.CrossRefPubMedPubMedCentral Turashvili G, Leung S, Turbin D, Montgomery K, Gilks B, West R, Carrier M, Huntsman D, Aparicio S: Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis. BMC Cancer. 2009, 9: 165-10.1186/1471-2407-9-165.CrossRefPubMedPubMedCentral
16.
go back to reference Turbin DA, Leung S, Cheang MC, Kennecke HA, Montgomery KD, McKinney S, Treaba DO, Boyd N, Goldstein LC, Badve S: Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat. 2008, 110: 417-426. 10.1007/s10549-007-9736-z.CrossRefPubMed Turbin DA, Leung S, Cheang MC, Kennecke HA, Montgomery KD, McKinney S, Treaba DO, Boyd N, Goldstein LC, Badve S: Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat. 2008, 110: 417-426. 10.1007/s10549-007-9736-z.CrossRefPubMed
17.
go back to reference Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J: ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 2010, 12: R56-10.1186/bcr2615.CrossRefPubMedPubMedCentral Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J: ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 2010, 12: R56-10.1186/bcr2615.CrossRefPubMedPubMedCentral
18.
go back to reference Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998, 4: 844-847. 10.1038/nm0798-844.CrossRefPubMed Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998, 4: 844-847. 10.1038/nm0798-844.CrossRefPubMed
19.
go back to reference de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M: Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer. 2007, 96: 1504-1513. 10.1038/sj.bjc.6603756.CrossRefPubMedPubMedCentral de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M: Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer. 2007, 96: 1504-1513. 10.1038/sj.bjc.6603756.CrossRefPubMedPubMedCentral
20.
go back to reference Domagala W, Markiewski M, Harezga B, Dukowicz A, Osborn M: Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin Cancer Res. 1996, 2: 147-154.PubMed Domagala W, Markiewski M, Harezga B, Dukowicz A, Osborn M: Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin Cancer Res. 1996, 2: 147-154.PubMed
21.
go back to reference Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Ferno M, Parwaresch R, Alm P: Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: Prognostic implications. J Pathol. 1999, 187: 207-216. 10.1002/(SICI)1096-9896(199901)187:2<207::AID-PATH223>3.0.CO;2-U.CrossRefPubMed Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Ferno M, Parwaresch R, Alm P: Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: Prognostic implications. J Pathol. 1999, 187: 207-216. 10.1002/(SICI)1096-9896(199901)187:2<207::AID-PATH223>3.0.CO;2-U.CrossRefPubMed
22.
go back to reference Stuart-Harris R, Caldas C, Pinder SE, Pharoah P: Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast. 2008, 17: 323-334. 10.1016/j.breast.2008.02.002.CrossRefPubMed Stuart-Harris R, Caldas C, Pinder SE, Pharoah P: Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast. 2008, 17: 323-334. 10.1016/j.breast.2008.02.002.CrossRefPubMed
23.
go back to reference Lundin M, Lundin J, Helin H, Isola J: A digital atlas of breast histopathology: an application of web based virtual microscopy. J Clin Pathol. 2004, 57: 1288-1291. 10.1136/jcp.2004.018739.CrossRefPubMedPubMedCentral Lundin M, Lundin J, Helin H, Isola J: A digital atlas of breast histopathology: an application of web based virtual microscopy. J Clin Pathol. 2004, 57: 1288-1291. 10.1136/jcp.2004.018739.CrossRefPubMedPubMedCentral
24.
go back to reference Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, Anttila A, Lundin M, Isola J, Lundin J: Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004, 292: 1064-1073. 10.1001/jama.292.9.1064.CrossRefPubMed Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, Anttila A, Lundin M, Isola J, Lundin J: Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004, 292: 1064-1073. 10.1001/jama.292.9.1064.CrossRefPubMed
25.
go back to reference Sihto H, Lundin J, Lehtimaki T, Sarlomo-Rikala M, Butzow R, Holli K, Sailas L, Kataja V, Lundin M, Turpeenniemi-Hujanen T: Molecular subtypes of breast cancers detected in mammography screening and outside of screening. Clin Cancer Res. 2008, 14: 4103-4110. 10.1158/1078-0432.CCR-07-5003.CrossRefPubMed Sihto H, Lundin J, Lehtimaki T, Sarlomo-Rikala M, Butzow R, Holli K, Sailas L, Kataja V, Lundin M, Turpeenniemi-Hujanen T: Molecular subtypes of breast cancers detected in mammography screening and outside of screening. Clin Cancer Res. 2008, 14: 4103-4110. 10.1158/1078-0432.CCR-07-5003.CrossRefPubMed
26.
go back to reference Konsti J, Lundin J, Jumppanen M, Lundin M, Viitanen A, Isola J: A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals. J Clin Pathol. 2008, 61: 278-282. 10.1136/jcp.2007.048991.CrossRefPubMed Konsti J, Lundin J, Jumppanen M, Lundin M, Viitanen A, Isola J: A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals. J Clin Pathol. 2008, 61: 278-282. 10.1136/jcp.2007.048991.CrossRefPubMed
27.
go back to reference Ruifrok AC, Johnston DA: Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001, 23: 291-299.PubMed Ruifrok AC, Johnston DA: Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001, 23: 291-299.PubMed
28.
go back to reference Cohen J: Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968, 70: 213-220. 10.1037/h0026256.CrossRefPubMed Cohen J: Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968, 70: 213-220. 10.1037/h0026256.CrossRefPubMed
29.
go back to reference Ahlin C, Aaltonen K, Amini RM, Nevanlinna H, Fjallskog ML, Blomqvist C: Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?. Histopathology. 2007, 51: 491-498. 10.1111/j.1365-2559.2007.02798.x.CrossRefPubMed Ahlin C, Aaltonen K, Amini RM, Nevanlinna H, Fjallskog ML, Blomqvist C: Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?. Histopathology. 2007, 51: 491-498. 10.1111/j.1365-2559.2007.02798.x.CrossRefPubMed
30.
go back to reference Fritz P, Wu X, Tuczek H, Multhaupt H, Schwarzmann P: Quantitation in immunohistochemistry. A research method or a diagnostic tool in surgical pathology?. Pathologica. 1995, 87: 300-309.PubMed Fritz P, Wu X, Tuczek H, Multhaupt H, Schwarzmann P: Quantitation in immunohistochemistry. A research method or a diagnostic tool in surgical pathology?. Pathologica. 1995, 87: 300-309.PubMed
31.
go back to reference Sapino A, Marchio C, Senetta R, Castellano I, Macri L, Cassoni P, Ghisolfl G, Cerrato M, D'Ambrosio E, Bussolati G: Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch. 2006, 449: 288-296. 10.1007/s00428-006-0233-2.CrossRefPubMed Sapino A, Marchio C, Senetta R, Castellano I, Macri L, Cassoni P, Ghisolfl G, Cerrato M, D'Ambrosio E, Bussolati G: Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch. 2006, 449: 288-296. 10.1007/s00428-006-0233-2.CrossRefPubMed
32.
go back to reference Klintman M, Bendahl PO, Grabau D, Lovgren K, Malmstrom P, Ferno M: The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer. Mod Pathol. 2010, 23: 251-259. 10.1038/modpathol.2009.167.CrossRefPubMed Klintman M, Bendahl PO, Grabau D, Lovgren K, Malmstrom P, Ferno M: The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer. Mod Pathol. 2010, 23: 251-259. 10.1038/modpathol.2009.167.CrossRefPubMed
33.
go back to reference Faratian D, Munro A, Twelves C, Bartlett JM: Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology. 2009, 54: 254-257. 10.1111/j.1365-2559.2008.03191.x.CrossRefPubMed Faratian D, Munro A, Twelves C, Bartlett JM: Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology. 2009, 54: 254-257. 10.1111/j.1365-2559.2008.03191.x.CrossRefPubMed
Metadata
Title
Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer
Publication date
01-12-2011
Published in
BMC Clinical Pathology / Issue 1/2011
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/1472-6890-11-3

Other articles of this Issue 1/2011

BMC Clinical Pathology 1/2011 Go to the issue